Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,701 to 1,720 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mmeta: An R Package for Multivariate Meta-Analysis. | J Stat Softw | 2014 | 24904241 | PubTator, text mining | PubMed |
| HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review. | J Immunol Res | 2014 | 24901010 | PubTator, text mining | PubMed |
| PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. | Pharmacogenet Genomics | 2014 | 24892773 | PubTator, text mining | PubMed |
| N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group. | Eur J Clin Pharmacol | 2014 | 24888881 | PubTator, text mining | PubMed |
| Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics. | BMC Genet | 2014 | 24884825 | PubTator, text mining | PubMed |
| Genetic basis of drug-induced liver injury: present and future. | Semin Liver Dis | 2014 | 24879978 | PubTator, text mining | PubMed |
| Recent developments in mycobacteriology: a clinical and diagnostic perspective. | Biomed Res Int | 2014 | 24877136 | PubTator, text mining | PubMed |
| Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials. | Drug Des Devel Ther | 2014 | 24868146 | PubTator, text mining | PubMed |
| Pharmacogenetics in Jewish populations. | Drug Metabol Drug Interact | 2014 | 24867283 | PubTator, text mining | PubMed |
| Role of early life exposure and environment on neurodegeneration: implications on brain disorders. | Transl Neurodegener | 2014 | 24847438 | PubTator, text mining | PubMed |
| From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2. | PLoS One | 2014 | 24823794 | PubTator, text mining | PubMed |
| Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population. | Med Oncol | 2014 | 24816842 | PubTator, text mining | PubMed |
| Future of pharmacogenetics-based therapy for tuberculosis. | Pharmacogenomics | 2014 | 24798717 | PubTator, text mining | PubMed |
| The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients. | Tuberculosis (Edinb) | 2014 | 24793319 | PubTator, text mining | PubMed |
| [The relationship between passive smoking, breast cancer risk and n-acetyltransferase 2 (NAT2)]. | Harefuah | 2014 | 24791559 | PubTator, text mining | PubMed |
| An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care. | PLoS One | 2014 | 24787444 | PubTator, text mining | PubMed |
| Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress. | J Gastroenterol Hepatol | 2014 | 24783247 | PubTator, text mining | PubMed |
| Integrative analysis of prognosis data on multiple cancer subtypes. | Biometrics | 2014 | 24766212 | PubTator, text mining | PubMed |
| Pharmacogenetics of drug metabolizing enzymes in Brazilian populations. | Drug Metabol Drug Interact | 2014 | 24744305 | PubTator, text mining | PubMed |
| Digging up the human genome: current progress in deciphering adverse drug reactions. | Biomed Res Int | 2014 | 24734245 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=86